300803:SZSEBeijing Compass Technology Development Co. Ltd. Class A Analysis
Data as of 2026-03-17 - not real-time
CN¥107.90
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Beijing Compass Technology Development trades at a **price of CNY 107.9**, which is far above its DCF‑derived fair value of **CNY 89.5** and its trailing PE of **291x**, dwarfing the industry average PE of **34x**. The stock carries a **high gross margin of 91%** and a solid operating margin of 17%, yet revenue is slightly contracting at **‑0.7%** YoY, indicating limited growth momentum. Technicals show the price sitting below the 20‑day SMA (113) and 50‑day SMA (124), with a **bearish MACD** and an RSI of **36**, suggesting modest short‑term downside pressure while still above the identified support at **CNY 103.2**. Volatility is elevated at **27.5%** over the past 30 days, but the beta of **0.22** points to low market‑wide systematic risk. The balance sheet is strong, boasting **CNY 11.44 bn** in cash against **CNY 1.0 bn** of debt (debt‑to‑equity 36%), and the company pays a negligible dividend of **0.08%** with a zero payout ratio, making the dividend sustainable but financially insignificant.
Given the stark valuation premium, muted growth, and bearish near‑term technical signals, the stock appears **overvalued** and more suited to investors seeking speculative upside rather than value. However, the ample liquidity, robust cash position, and low correlation to broader market moves temper the overall risk profile, positioning the stock at a **moderate risk** level for medium‑ to long‑term holders who may anticipate a strategic turnaround or sector‑wide recovery.
Given the stark valuation premium, muted growth, and bearish near‑term technical signals, the stock appears **overvalued** and more suited to investors seeking speculative upside rather than value. However, the ample liquidity, robust cash position, and low correlation to broader market moves temper the overall risk profile, positioning the stock at a **moderate risk** level for medium‑ to long‑term holders who may anticipate a strategic turnaround or sector‑wide recovery.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below short‑term moving averages
- Bearish MACD histogram
- High valuation relative to peers
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong cash position offsets debt
- Stable high margins despite flat revenue
- Moderate volatility with low beta
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential for strategic pivots in software services
- Continued low dividend payout limits income appeal
- Sector regulatory environment remains uncertain
Key Metrics & Analysis
Financial Health
Revenue Growth-0.70%
Profit Margin10.55%
P/E Ratio291.6
ROE9.04%
ROA0.15%
Debt/Equity36.20
P/B Ratio23.6
Op. Cash FlowCN¥3.1B
Free Cash FlowCN¥3.3B
Industry P/E34.2
Technical Analysis
TrendNeutral
RSI36.3
SupportCN¥103.23
ResistanceCN¥121.70
MA 20CN¥113.08
MA 50CN¥124.52
MA 200CN¥115.56
MACDBearish
VolumeIncreasing
Fear & Greed Index79.45
Valuation
Fair ValueCN¥89.51
GradeOvervalued
TypeGrowth
Dividend Yield0.08%
Risk Assessment
Beta0.22
Volatility27.55%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.